| Advanced age is an independent risk factor for severe infections and mortality in patients given anti–tumor necrosis factor therapy for inflammatory bowel disease M Cottone, A Kohn, M Daperno, A Armuzzi, L Guidi, R D'Inca, F Bossa, ... Clinical Gastroenterology and Hepatology 9 (1), 30-35, 2011 | 378 | 2011 |
| The effect of zinc and vitamin A supplementation on immune response in an older population C Fortes, F Forastiere, N Agabiti, V Fano, R Pacifici, F Virgili, G Piras, ... Journal of the American Geriatrics Society 46 (1), 19-26, 1998 | 207 | 1998 |
| Paroxetine and fluoxetine effects on mood and cognitive functions in depressed nondemented elderly patients GB Cassano, F Puca, PL Scapicchio, M Trabucchi, ... Journal of Clinical Psychiatry 63 (5), 396-402, 2002 | 167 | 2002 |
| Dermatological adverse reactions during anti-TNF treatments: focus on inflammatory bowel disease G Mocci, M Marzo, A Papa, A Armuzzi, L Guidi Journal of Crohn's and Colitis 7 (10), 769-779, 2013 | 157 | 2013 |
| The PROSIT-BIO cohort: a prospective observational study of patients with inflammatory bowel disease treated with infliximab biosimilar G Fiorino, N Manetti, A Armuzzi, A Orlando, A Variola, S Bonovas, ... Inflammatory bowel diseases 23 (2), 233-243, 2017 | 150 | 2017 |
| Management of perianal fistulas in Crohn’s disease: an up-to-date review M Marzo, C Felice, D Pugliese, G Andrisani, G Mocci, A Armuzzi, L Guidi World Journal of Gastroenterology: WJG 21 (5), 1394, 2015 | 139 | 2015 |
| Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti‐TNF alpha: 5‐year follow‐up study D Pugliese, L Guidi, PM Ferraro, M Marzo, C Felice, L Celleno, R Landi, ... Alimentary pharmacology & therapeutics 42 (7), 880-888, 2015 | 112 | 2015 |
| Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: effects of combined therapy with immunosuppressants G Andrisani, D Frasca, M Romero, A Armuzzi, C Felice, M Marzo, ... Journal of Crohn's and Colitis 7 (4), 301-307, 2013 | 108 | 2013 |
| Early atherosclerosis in patients with inflammatory bowel disease A Papa, S Danese, R Urgesi, A Grillo, S Guglielmo, I Roberto, M Bonizzi, ... European review for medical and pharmacological sciences 10 (1), 7, 2006 | 108 | 2006 |
| Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study A Armuzzi, C Felice, A Papa, M Marzo, D Pugliese, G Andrisani, ... Journal of Crohn's and Colitis 7 (12), e623-e629, 2013 | 106 | 2013 |
| Anti TNF-α therapy for ulcerative colitis: current status and prospects for the future D Pugliese, C Felice, A Papa, A Gasbarrini, GL Rapaccini, L Guidi, ... Expert Review of Clinical Immunology 13 (3), 223-233, 2017 | 105 | 2017 |
| Ileal Crohn disease: mural microvascularity quantified with contrast-enhanced US correlates with disease activity A De Franco, A Di Veronica, A Armuzzi, I Roberto, M Marzo, ... Radiology 262 (2), 680-688, 2012 | 104 | 2012 |
| Infliximab in steroid-dependent ulcerative colitis: effectiveness and predictors of clinical and endoscopic remission A Armuzzi, D Pugliese, S Danese, G Rizzo, C Felice, M Marzo, ... Inflammatory bowel diseases 19 (5), 1065-1072, 2013 | 101 | 2013 |
| Increased carotid intima–media thickness in patients with inflammatory bowel disease A Papa, A Santoliquido, S Danese, M Covino, CD Campli, R Urgesi, ... Alimentary pharmacology & therapeutics 22 (9), 839-846, 2005 | 100 | 2005 |
| Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndrome L Passerini, S Di Nunzio, S Gregori, E Gambineri, M Cecconi, MG Seidel, ... European journal of immunology 41 (4), 1120-1131, 2011 | 96 | 2011 |
| Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis A Armuzzi, D Pugliese, S Danese, G Rizzo, C Felice, M Marzo, ... Inflammatory bowel diseases 20 (8), 1368-1374, 2014 | 91 | 2014 |
| Adalimumab in active ulcerative colitis: a “real-life” observational study A Armuzzi, L Biancone, M Daperno, A Coli, D Pugliese, V Annese, ... Digestive and Liver Disease 45 (9), 738-743, 2013 | 89 | 2013 |
| Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents A Papa, C Felice, M Marzo, G Andrisani, A Armuzzi, M Covino, G Mocci, ... Journal of Crohn's and Colitis 7 (2), 113-119, 2013 | 89 | 2013 |
| Faecal calprotectin assay after induction with anti-tumour necrosis factor α agents in inflammatory bowel disease: prediction of clinical response and mucosal healing at one year L Guidi, M Marzo, G Andrisani, C Felice, D Pugliese, G Mocci, O Nardone, ... Digestive and Liver Disease 46 (11), 974-979, 2014 | 88 | 2014 |
| Harmful effects and potential benefits of anti-tumor necrosis factor (TNF)-α on the liver LR Lopetuso, G Mocci, M Marzo, F D’Aversa, GL Rapaccini, L Guidi, ... International journal of molecular sciences 19 (8), 2199, 2018 | 86 | 2018 |
Alfredo PapaFondazione Policlinico Gemelli, IRCCS. Università Cattolica del S. Cuore在 unicatt.it 的电子邮件经过验证
